Global central lab market is estimated to be valued at USD 3.63 Bn in 2025 and is expected to reach USD 5.76 Bn by 2032

BURLINGAME, CA, UNITED STATES, November 17, 2025 /EINPresswire.com/ -- Global Central Lab Market is estimated to be valued at USD 3.63 Bn in 2025 and is expected to reach USD 5.76 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032. The global central lab market is poised for steady growth throughout the forecast period, driven by the rising volume of diagnostic testing, growing incidence of chronic and infectious diseases, continuous advancements in diagnostic technologies, and the increasing need for early and precise disease detection.

Global Central Lab Market Key Takeaways

According to Coherent Market Insights (CMI), the global central lab market size is projected to total USD 3.63 Bn in 2025 and USD 5.76 Bn by 2032, growing at a CAGR of 6.8%.

Demand is expected to remain high for genetic services, with the target segment accounting for 30.5% of the global central lab market share by 2025.

Based on end user, pharmaceutical companies category is anticipated to hold a market share of 35% in 2025.

North America is expected to dominate the global central lab industry, capturing nearly two-fifths of the market share by 2025.

Asia Pacific is poised to emerge as a highly lucrative pocket for global central lab market companies during the forecast period.

Increasing Clinical Trials Spurring Market Growth

Coherent Market Insights’ latest global central lab market analysis highlights key factors driving market growth. Increasing number of clinical trials globally is one such prominent growth factor.

Pharmaceutical and biotech companies in the contemporary world are initiating more trials for new treatments. For instance, ClinicalTrials.gov lists a total of 552,796 clinical studies conducted across all 51 U.S. states and in 224 countries and territories.

This rise in clinical trials is driving demand for central lab services, and the trend will likely continue during the forecast period. Central labs play a key role in ensuring consistent data across multiple trial sites.

Central labs support clinical trials by testing samples, including genetic and biomarker testing. As the number of clinical trials increases, so will demand for central lab services.

Buy the Complete Report with an Impressive Discount (Up to 25% Off ) at: https://www.coherentmarketinsights.com/insight/buy-now/7187

High Diagnostic Costs Hampering Market Growth

The global central lab market outlook looks promising. However, high cost of diagnostic tests might limit market growth to some extent during the forecast period.

Advanced diagnostic tests are often very expensive, which can be difficult for regions with limited resources. These expenses can prevent both doctors and patients from using central lab services, potentially limiting global central lab market demand.

Rising Prevalence of Chronic and Genetic Diseases Creating Growth Opportunities

The global incidence of chronic and genetic diseases such as cancer, diabetes, cardiovascular disorders, cystic fibrosis, and sickle cell anemia is increasing significantly. This is expected to drive demand for specialized testing and diagnostic services, thereby creating growth avenues within the central lab market.

Emerging Global Central Lab Market Trends

Rising trend of outsourcing laboratory services is expected to boost growth of the global central lab market during the forecast period. Pharmaceutical and biotech companies are increasingly outsourcing lab services to central labs to reduce costs as well as accelerate timelines and use specialized expertise.

Increasing adoption of personalized medicine is creating new growth opportunities for central lab service providers. Precision medicine and biomarker-driven trials often require specialized testing capabilities, which central labs are equipped to provide.

Growing use of advanced technology in central labs is helping the market grow. Many central labs are employing automation, robotics, AI, cloud-based data systems, and other digital platforms to save time and money, reduce human errors, and improve efficiency.

Competitor Insights

Key companies in the global central lab market report:

Barc Lab (Cerba Research)
ACM Global Laboratories
Eurofins Central Laboratory
Celerion
CIRION BioPharma Research
Bioscientia (Sonic Healthcare)
Frontage Laboratories, Inc.
Clinical Reference Laboratory
InVitro International
ICON Central Laboratories
INTERLAB Central Lab Services
Labcorp/Covance
MLM Medical Labs GmbH
Medpace
Q² Solutions
LabConnect
PPD

Detailed Segmentation-

By Services: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services
By End User: Pharmaceutical companies Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Others

Key Developments

In August 2025, LabConnect, LLC launched the LabConnector, a new, powerful technology solution that transforms the way laboratory data is exchanged and managed for clinical trials. It has the tendency to standardize diverse laboratory data into a single HL7 format.

In March 2025, IQVIA Laboratories launched Site Lab Navigator, a new tool to make lab work easier and faster. It helps automate and organize workflows for clinical trial sponsors and investigator sites.

About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Raj Shah
Coherent Market Insights Pvt. Ltd.
+1 252-477-1362
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]